Research I 14 October 2025
Novel EuroACT methodology just published!
We are proud to share EuroACT’s new article:
“Methodological study protocol for The European Atlas of Clinical Trials in Cancer and Haematology.”
This peer-reviewed paper, developed and reviewed by scientific experts, confirms the robustness of the Atlas approach.
The Atlas will:
- Map cancer & haematology trials across Europe
- Expose gaps in access
- Provide robust evidence to support patient advocates in driving equity
- For patients, this means clearer information, stronger advocacy, and fairer access to innovation.
👉 Read the publication here: [https://myfrontiers.frontiersin.org/projects/submission/1558556]
ABOUT THE PROJECT
EuroACT is a research project initiated by WECAN and the European Hematology Community. The project aims to understand the clinical trial landscape in the European region, based on data extracted from all relevant European clinical trial registers. Data from the past five years will unveil differences where clinical trials have been run in European countries and will describe how and which patient-reported outcomes (PROs) and quality-of-life (QoL) instruments have been used in clinical trials.
